Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AstraZeneca
Biotech
AZ's 'science success story' with tozorakimab plays out in full
With detailed results on a ph. 3 win, AstraZeneca has secured an FDA priority review for what it believes could become a flagship biologic in COPD.
Fraiser Kansteiner
Sep 8, 2026 10:50am
Fierce Pharma
FDA's surprise approval of AZ's oral SERD sets new paradigm
Sep 8, 2026 10:35am
Guardant wins FDA nod for test guiding AstraZeneca’s Etcamah
Sep 7, 2026 2:08am
A year after Big Pharma’s pull-back from the UK, what’s changed?
Sep 4, 2026 10:00am
Don't count out Alnylam's next-gen silencer in ATTR-CM: analysts
Sep 1, 2026 1:55pm
AstraZeneca's heart failure drug shows promise in ph. 2 trial
Aug 31, 2026 11:13am
